WESTLAKE VILLAGE, CA / ACCESSWIRE / October 9, 2020 / Inspyr Therapeutics, Inc. (OTC/PINK:NSPX), announces that it has acquired a novel immuno-oncology delivery technology targeting adenosine receptor ...

Add Yahoo as a preferred source to see more of our stories on Google. Inspyr, founded by Nadia Williams, is raising awareness for breast cancer survivors with their “More Than Just a Pink Ribbon” ...

WESTLAKE VILLAGE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Inspyr Therapeutics, Inc. (“Inspyr”) is announcing (i) a 1-for-75 reverse stock split of its common stock and (ii) a holding company ...

WESTLAKE VILLAGE, CA / ACCESSWIRE / January 12, 2021 / Inspyr Therapeutics, Inc. (OTC PINK:NSPX), a pharmaceutical company focused on the research and development of novel targeted precision ...

Commitment of up to $100 Million in Total Proceeds Transaction Subject to Definitive Agreement WESTLAKE VILLAGE, Calif., March 17, 2017 (GLOBE NEWSWIRE) -- Inspyr Therapeutics (OTCQB:NSPXD), a ...

SAN ANTONIO--(BUSINESS WIRE)--Inspyr Therapeutics, Inc. (OTCQB: NSPX), a clinical-stage biotechnology company developing novel prodrug therapeutics for the treatment of cancer, announces the ...

The boards of biotech firms Inspyr Therapeutics and Lewis and Clark Pharmaceuticals have approved a merger deal through which Inspyr will acquire Lewis and Clark in an all-stock transaction. No ...

PLANO, Texas--(BUSINESS WIRE)--BGSF, Inc. (NYSE: BGSF), a leading provider of consulting, managed services, and professional workforce solutions, announced today that it has signed a definitive ...

Preclinical data demonstrated delayed tumor growth, reduces metastases and anti-tumor immune response WESTLAKE VILLAGE, CA / ACCESSWIRE / October 9, 2020 / Inspyr Therapeutics, Inc. (OTC/PINK:NSPX), ...

Proceeds support the development of lead asset, RT-AR001, an adenosine receptor antagonist Funds were secured from an existing institutional investor The Debenture (i) is non-interest bearing, (ii) ...